Vistra Corp.: Form 10-Q for the period ended Mar 31, 2024
Filed with the SEC on May 10, 2024 and accepted by EDGAR at May 9, 2024, 22:49 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2024-03-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2024-01-01 to 2024-03-31 | $3.16bn | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Selling, general and administrative | 3 months2024-01-01 to 2024-03-31 | $351.0m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months2024-01-01 to 2024-03-31 | $86.0m | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months2024-01-01 to 2024-03-31 | $170.0m | us-gaap:InterestExpense |
| Income tax | 3 months2024-01-01 to 2024-03-31 | −$20.0m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2024-01-01 to 2024-03-31 | −$35.0m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2024-01-01 to 2024-03-31 | −$0.24 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2024-01-01 to 2024-03-31 | −$0.24 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2024-01-01 to 2024-03-31 | 348,966,197 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 3 months2024-01-01 to 2024-03-31 | $312.0m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 3 months2024-01-01 to 2024-03-31 | $465.0m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Dividends paid | 3 months2024-01-01 to 2024-03-31 | $77.0m | us-gaap:PaymentsOfDividendsCommonStock |
| Share repurchases | 3 months2024-01-01 to 2024-03-31 | $291.0m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | At period end2024-03-31 | $1.07bn | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2024-03-31 | $9.43bn | us-gaap:AssetsCurrent |
| Total assets | At period end2024-03-31 | $38.18bn | us-gaap:Assets |
| Current liabilities | At period end2024-03-31 | $8.78bn | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2024-03-31 | $30.89bn | us-gaap:Liabilities |
| Short-term borrowings | At period end2024-03-31 | $500.0m | us-gaap:ShortTermBorrowings |
| Shareholders' equity | At period end2024-03-31 | $5.66bn | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001692819-24-000033. Last ingested by Listed: Oct 24, 2026, 15:07 ET. Listed shows no prices and gives no investment advice.